Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of SGLT2-Inhibitor Therapy on Survival in Patients with Transthyretin Amyloid Cardiomyopathy: Analysis of a Prospective Registry Study.
Schwegel N, Toferer C, Zach DK, Santner V, Höller V, Lugitsch J, Wallner M, Gollmer J, Aziz F, von Lewinski D, Kolesnik E, Ablasser K, Zirlik A, Sourij H, Verheyen N. Schwegel N, et al. Among authors: santner v. J Clin Med. 2024 Oct 8;13(19):5966. doi: 10.3390/jcm13195966. J Clin Med. 2024. PMID: 39408026 Free PMC article.
Impact of empagliflozin on cardiac structure and function assessed by echocardiography after myocardial infarction: a post-hoc sub-analysis of the emmy trial.
Schwegel N, Strohhofer C, Kolesnik E, Oltean S, Hüttmair A, Pipp C, Benedikt M, Verheyen N, Gollmer J, Ablasser K, Wallner M, Santner V, Tripolt N, Pferschy P, Zechner P, Alber H, Siller-Matula JM, Kopp K, Zirlik A, Aziz F, Sourij H, von Lewinski D. Schwegel N, et al. Among authors: santner v. Clin Res Cardiol. 2024 Sep 16. doi: 10.1007/s00392-024-02523-1. Online ahead of print. Clin Res Cardiol. 2024. PMID: 39297940
Prevalence and prognostic impact of bone disease in chronic heart failure with reduced ejection fraction.
Verheyen N, Schmid J, Kolesnik E, Schwegel N, Späth J, Kattnig L, Riepl H, Zach D, Santner V, Höller V, Pilz S, Tomaschitz A, Fuchsjäger M, Fahrleitner-Pammer A, Dimai HP, Obermayer-Pietsch B, Fruhwald F, Scherr D, Zirlik A, von Lewinski D, Ablasser K. Verheyen N, et al. Among authors: santner v. ESC Heart Fail. 2024 Jun;11(3):1730-1738. doi: 10.1002/ehf2.14741. Epub 2024 Mar 7. ESC Heart Fail. 2024. PMID: 38450879 Free PMC article.
Low-grade systemic inflammation and left ventricular dysfunction in hypertensive compared to non-hypertensive hypertrophic cardiomyopathy.
Zach DK, Schwegel N, Santner V, Winkelbauer L, Hoeller V, Kolesnik E, Gollmer J, Seggewiss H, Batzner A, Perl S, Wallner M, Reiter U, Rainer PP, Zirlik A, Ablasser K, Verheyen N. Zach DK, et al. Among authors: santner v. Int J Cardiol. 2024 Mar 15;399:131661. doi: 10.1016/j.ijcard.2023.131661. Epub 2023 Dec 27. Int J Cardiol. 2024. PMID: 38158132 Free article.
Non-eligibility for pivotal HFpEF/HFmrEF outcome trials and mortality in a contemporary heart failure cohort.
Santner V, Riepl HS, Posch F, Wallner M, Rainer PP, Ablasser K, Kolesnik E, Hoeller V, Zach D, Schwegel N, Kreuzer P, Lueger A, Petutschnigg J, Pieske B, Zirlik A, Edelmann F, Verheyen N. Santner V, et al. Eur J Intern Med. 2023 Dec;118:73-81. doi: 10.1016/j.ejim.2023.07.027. Epub 2023 Jul 28. Eur J Intern Med. 2023. PMID: 37517939 Free article.